Product Information
CICLOPIROX 0.77% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1687 per GM under NDC 45802013811. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ciclopirox olamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.7 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802013811
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROX OLAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA077364FDA Approved
3/3/2006
TE Code
AB
On Market Since
7/19/2006
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 0.77% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 48.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per GM |
|---|---|
| All-time high | $0.5583 (Aug 13, 2014) |
| All-time low | $0.1620 (Nov 20, 2024) |
| 52-week high | $0.1992 |
| 52-week low | $0.1659 |
| Median price | $0.2198 |
| Average price | $0.2560 |
| Largest weekly change | +64.2% (Feb 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciclopirox olamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 0.77% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1687 per GM (NDC 45802013811), effective Sep 30, 2026.
How has the price of CICLOPIROX 0.77% CREAM changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 0.77% CREAM has declined 48.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% CREAM?
Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% CREAM has ranged from a low of $0.1620 (Nov 20, 2024) to a high of $0.5583 (Aug 13, 2014), with a median of $0.2198 per GM.
Are there cheaper alternatives to CICLOPIROX 0.77% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CICLOPIROX 0.77% CREAM, is $0.1025 per GM — about 39% below CICLOPIROX 0.77% CREAM.
Who manufactures CICLOPIROX 0.77% CREAM?
CICLOPIROX 0.77% CREAM (NDC 45802013811) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.